Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F7THR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,735
Award facts
- Contract value 100% obligated
- $5,734.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $5,734.80 delivery order to Amerisourcebergen Drug Corp on July 16, 2026, for Monjaro 2.5 mg/0.5 ml pen injectable medication, with an ultimate completion date of July 17, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor supplying medications and medical devices to the Department of Defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7THR?
SPE2DR26F7THR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 16, 2026.
How much is contract SPE2DR26F7THR worth?
The government has obligated $5,735 on SPE2DR26F7THR.
Is contract SPE2DR26F7THR an order under another contract?
Yes. SPE2DR26F7THR is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7THR competed?
The extent of competition for SPE2DR26F7THR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award